IT1224574B - Fattore di attivazione di leucociti neutrofili, procedimento di preparazione, nonche' composizioni farmaceutiche che lo contengono - Google Patents
Fattore di attivazione di leucociti neutrofili, procedimento di preparazione, nonche' composizioni farmaceutiche che lo contengonoInfo
- Publication number
- IT1224574B IT1224574B IT8848572A IT4857288A IT1224574B IT 1224574 B IT1224574 B IT 1224574B IT 8848572 A IT8848572 A IT 8848572A IT 4857288 A IT4857288 A IT 4857288A IT 1224574 B IT1224574 B IT 1224574B
- Authority
- IT
- Italy
- Prior art keywords
- neutrofile
- leukocytes
- contain
- pharmaceutical compositions
- preparation procedure
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/53—Colony-stimulating factor [CSF]
- C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- C07K14/5421—IL-8
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Toxicology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Virology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB878727053A GB8727053D0 (en) | 1987-11-19 | 1987-11-19 | Neutrophil-activating factor(naf) |
GB888805070A GB8805070D0 (en) | 1988-03-03 | 1988-03-03 | Neutrophil-activating factor(naf) |
GB888825258A GB8825258D0 (en) | 1988-10-28 | 1988-10-28 | Neutrophil-activating factor |
Publications (2)
Publication Number | Publication Date |
---|---|
IT8848572A0 IT8848572A0 (it) | 1988-11-18 |
IT1224574B true IT1224574B (it) | 1990-10-04 |
Family
ID=27263673
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IT8848572A IT1224574B (it) | 1987-11-19 | 1988-11-18 | Fattore di attivazione di leucociti neutrofili, procedimento di preparazione, nonche' composizioni farmaceutiche che lo contengono |
Country Status (23)
Country | Link |
---|---|
US (1) | US6383479B1 (it) |
JP (1) | JP3133305B2 (it) |
KR (1) | KR890701625A (it) |
AT (1) | ATA901588A (it) |
AU (1) | AU622125B2 (it) |
BE (1) | BE1001817A5 (it) |
CH (1) | CH680001A5 (it) |
DE (2) | DE3890998B4 (it) |
DK (1) | DK354389A (it) |
ES (1) | ES2014546A6 (it) |
FI (1) | FI893474A0 (it) |
FR (1) | FR2623400B1 (it) |
GB (1) | GB2223225B (it) |
GR (1) | GR880100775A (it) |
HU (1) | HU205617B (it) |
IL (1) | IL88404A0 (it) |
IT (1) | IT1224574B (it) |
NL (1) | NL194982C (it) |
NZ (1) | NZ226990A (it) |
PL (1) | PL275881A1 (it) |
PT (1) | PT89026B (it) |
SE (1) | SE8902507L (it) |
WO (1) | WO1989004836A1 (it) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5652338A (en) * | 1988-03-16 | 1997-07-29 | The United States Of America As Represented By The Department Of Health And Human Services | Neutrophil chemotactic factor |
WO1990000563A1 (en) * | 1988-07-07 | 1990-01-25 | United States Government, As Represented By The Department Of Health & Human Services | A method of treating diseases caused by immunodeficiency states by administering human neutrophil chemotactic factor to human |
JPH04500076A (ja) * | 1988-08-15 | 1992-01-09 | ブリガム・アンド・ウイメンズ・ホスピタル | 白血球付着阻害物質 |
WO1990002178A1 (en) * | 1988-08-29 | 1990-03-08 | THE UNITED STATES GOVERNMENT, as represented by THE DEPARTMENT OF HEALTH & SERVICES | A method of preparing an active human neutrophil chemotactic factor polypeptide |
JP2844260B2 (ja) * | 1988-11-10 | 1999-01-06 | ステファン チャールズ マックケイブ | シャワーヘッド組立体 |
US5241049A (en) * | 1989-12-22 | 1993-08-31 | Zymogenetics, Inc. | Neutrophil chemoattractants |
US5079228A (en) * | 1990-02-05 | 1992-01-07 | Board Of Regents, The University Of Texas System | Peptide inhibitors of neutrophil activating factor induced chemotaxis |
IE913192A1 (en) * | 1990-09-12 | 1992-02-25 | Scripps Research Inst | Active site of interleukin-8: polypeptide analogs and¹antibodies |
AU2348492A (en) * | 1991-07-19 | 1993-02-23 | East Carolina University | Method of treating asthma |
US5401651A (en) * | 1991-10-16 | 1995-03-28 | Walz; Alfred | DNA encoding ENA-78, a neutrophil activating factor |
GB9124775D0 (en) * | 1991-11-21 | 1992-01-15 | Medical Res Council | Cervical ripening |
AU3078892A (en) * | 1991-12-04 | 1993-06-28 | Biomedical Research Centre Limited, The | Human interleukin-8 analogs |
GB9807721D0 (en) * | 1998-04-08 | 1998-06-10 | Chiron Spa | Antigen |
US20220308046A1 (en) * | 2019-06-27 | 2022-09-29 | Binary Llc | Oxidase-based chemiluminescence assay of phagocytic leukocytes in whole blood and body fluids applicable to point-of-care (poc) diagnostic testing point-of-care (poc) measurement of absolute neutrophil function (anf) |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3737703A1 (de) * | 1987-11-06 | 1989-05-18 | Ferring Arzneimittel Gmbh | Neutrophilen aktivierendes polypeptid, verfahren zu dessen herstellung sowie dessen verwendung als arzneimittel und diagnostikum |
US5652338A (en) * | 1988-03-16 | 1997-07-29 | The United States Of America As Represented By The Department Of Health And Human Services | Neutrophil chemotactic factor |
DE68920321T2 (de) | 1988-05-02 | 1995-05-24 | Us Health | Verfahren zur herstellung eines menschlichen "neutrophil chemotactic factor"-polypeptids. |
JPH04500076A (ja) | 1988-08-15 | 1992-01-09 | ブリガム・アンド・ウイメンズ・ホスピタル | 白血球付着阻害物質 |
AU4665689A (en) * | 1989-12-11 | 1991-07-18 | Wallac Oy | Elastic scintillator material |
-
1988
- 1988-11-12 JP JP63509434A patent/JP3133305B2/ja not_active Expired - Lifetime
- 1988-11-12 DE DE3890998A patent/DE3890998B4/de not_active Expired - Lifetime
- 1988-11-12 WO PCT/EP1988/001025 patent/WO1989004836A1/en active Application Filing
- 1988-11-12 DE DE883890998T patent/DE3890998T1/de active Pending
- 1988-11-12 CH CH2553/89A patent/CH680001A5/de not_active IP Right Cessation
- 1988-11-12 AU AU27162/88A patent/AU622125B2/en not_active Ceased
- 1988-11-12 HU HU886790A patent/HU205617B/hu not_active IP Right Cessation
- 1988-11-12 NL NL8820928A patent/NL194982C/nl not_active IP Right Cessation
- 1988-11-12 GB GB8913271A patent/GB2223225B/en not_active Expired - Lifetime
- 1988-11-12 AT AT0901588A patent/ATA901588A/de not_active Application Discontinuation
- 1988-11-16 GR GR880100775A patent/GR880100775A/el unknown
- 1988-11-17 IL IL88404A patent/IL88404A0/xx unknown
- 1988-11-17 NZ NZ226990A patent/NZ226990A/en unknown
- 1988-11-17 PT PT89026A patent/PT89026B/pt active IP Right Grant
- 1988-11-18 IT IT8848572A patent/IT1224574B/it active
- 1988-11-18 ES ES8803530A patent/ES2014546A6/es not_active Expired - Lifetime
- 1988-11-18 FR FR8815025A patent/FR2623400B1/fr not_active Expired - Lifetime
- 1988-11-18 PL PL27588188A patent/PL275881A1/xx unknown
- 1988-11-18 BE BE8801310A patent/BE1001817A5/fr not_active IP Right Cessation
-
1989
- 1989-07-11 SE SE8902507A patent/SE8902507L/ not_active Application Discontinuation
- 1989-07-18 KR KR1019890701346A patent/KR890701625A/ko not_active Application Discontinuation
- 1989-07-18 FI FI893474A patent/FI893474A0/fi not_active Application Discontinuation
- 1989-07-18 DK DK354389A patent/DK354389A/da not_active Application Discontinuation
-
1995
- 1995-06-06 US US08/466,546 patent/US6383479B1/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL79235A0 (en) | Pharmaceutical compositions containing solubilized proteins and their preparation | |
FR2582513B1 (fr) | Compositions pharmaceutiques contenant de l'alfuzosine | |
IT1213379B (it) | Tiazolo [4,5-c]chinoline, procedimento per la loro preparazione e composizioni farmaceutiche che le contengono. | |
GR871659B (en) | Substituted a-aminoacids their preparation and pharmaceutical compositions containing them | |
IL84832A (en) | 6-benzoxazinyl- and 6-benzothiazinyl-2,3,4,5- tetrahydropyridazin-3- ones, their preparation and pharmaceutical compositions containing them | |
IT1224574B (it) | Fattore di attivazione di leucociti neutrofili, procedimento di preparazione, nonche' composizioni farmaceutiche che lo contengono | |
FR2607502B1 (fr) | Derives de l'imidazole, leur preparation et compositions medicamenteuses les contenant | |
MC1847A1 (fr) | Fragments d'interferons imnuns recombinants,homogenes et composition pharmaceutiques les contenant | |
IT1241631B (it) | "n,n'-ditrimetossibenzoilpiperazine 2-sostituite, procedimento per la loro preparazione e composizioni terapeutiche che le contengono | |
PT84184A (pt) | Process for the preparation of 8 alpha-acylaminoergolines and of pharmaceutical compositions containing them | |
IT8620136A0 (it) | (-)-1beta-etil-1alfa-idrossimentil1,2,3,4,6,7,12,12balfa-ottaidroindo lo [2,3-a] chinolizina, procedimento per la sua preparazione e composizioni farmaceutiche che la contengono | |
IT8922446A0 (it) | Procedimento per la preparazione di primicina idrosolubile e suoi componenti e composizioni farmaceutiche che li contengono | |
KR900700471A (ko) | 신규의 2,3-티오모르폴린디온-2-옥심유도체, 이들을 함유하는 약제학적 조성물 및 제법 | |
FR2601950B1 (fr) | N,n-dimethyl-n'-benzoyl-n' ((2,3-dihydro) benzofuran-2-yl-methyl) 1,3-propanediamine, preparation et compositions pharmaceutiques les contenant | |
IT1204839B (it) | Composizioni farmaceutiche contenenti vinburnina e loro procedimento di preparazione | |
IT8822858A0 (it) | Composizioni per la riduzione di flebectasie e procedimento per la loro preparazione | |
IT8520514A0 (it) | Composizioni di farmaci dotate di attivita' antimicrobica eprocedimento per la loro preparazione. | |
NL185666C (nl) | Farmaceutisch preparaat of voorwerp en geneeskrachtige verbindingen. | |
IT8519620A0 (it) | Procedimento per la preparazione di amidinouree e composizioni farmaceutiche che le contengono | |
IT8520515A0 (it) | Composizioni di farmaci eprocedimento per la loro preparazione. | |
IT8622051A0 (it) | Composizioni farmaceutiche adattivita' cicatrizzante. | |
IT1237343B (it) | Dicloridrato di acetildicarnitina, procedimento per la sua preparazione e composizioni farmaceutiche che lo contengono | |
IT8921961A0 (it) | Metodo per l'ottenimento di silibinina e composizioni farmaceutiche che contengono la stessa | |
ITMI922241A0 (it) | Composto con attivita' vasodilatatrice procedimento per la sua preparazione e composizioni farmaceutiche che lo contengono | |
IT8720226A0 (it) | Composto con attivita'vasodilatatrice, procedimento per la sua preparazione e composizioni farmaceutiche che lo contengono. |